.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cerilliant
Mallinckrodt
Healthtrust
Chubb
Deloitte
Colorcon
Julphar
Fuji
Merck

Generated: September 19, 2017

DrugPatentWatch Database Preview

Hetero Labs Ltd V Company Profile

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?

HETERO LABS LTD V has twenty-three approved drugs.

There are five tentative approvals on HETERO LABS LTD V drugs.

Summary for Applicant: Hetero Labs Ltd V

Patents:0
Tradenames:22
Ingredients:21
NDAs:23
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd V
LAMIVUDINE
lamivudine
TABLET;ORAL203260-001Jan 2, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
VALSARTAN
valsartan
TABLET;ORAL203311-002Jan 5, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
ARIPIPRAZOLE
aripiprazole
TABLET;ORAL205064-002Apr 28, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
SILDENAFIL CITRATE
sildenafil citrate
TABLET;ORAL203623-001Nov 26, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
LEVOFLOXACIN
levofloxacin
TABLET;ORAL202801-002Jan 8, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL203034-001Jan 30, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
ROSUVASTATIN CALCIUM
rosuvastatin calcium
TABLET;ORAL207616-003Oct 31, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
LINEZOLID
linezolid
TABLET;ORAL204239-001Dec 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
MONTELUKAST SODIUM
montelukast sodium
TABLET, CHEWABLE;ORAL204093-002May 22, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
ROSUVASTATIN CALCIUM
rosuvastatin calcium
TABLET;ORAL207616-001Oct 31, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cerilliant
QuintilesIMS
Harvard Business School
Johnson and Johnson
AstraZeneca
Colorcon
UBS
Teva
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot